GLP-1s vs Bariatric Surgery; Obesity Trends Reversing; Creatine for Menopause?

(MedPage Today) -- GLP-1 medication use increased by 140.4% from 2022 to 2024 while metabolic bariatric surgery utilization declined by 34.1%, national insurance data indicated. (JAMA Surgery) Generic forms of semaglutide (Ozempic, Wegovy) aren...
Source
MedPage Today
Opens original article in a new tab



